Retatrutide is a synthetic research peptide studied in preclinical research for its potential impact on metabolism, body composition, and energy regulation. Preclinical research suggests it may influence pathways related to appetite control, glucose metabolism, and fat reduction through its multi-receptor activity on GLP-1, GIP, and glucagon receptors. Studies have also explored its potential to improve insulin sensitivity and support healthy metabolic function.
For research use only — not for human consumption, medical, or therapeutic use.
